NeoProteomics Receives $300K SBIR Grant to Develop Software for Personalized Medicine Tools | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NeoProteomics announced on Tuesday it has been awarded a two-year, $300,000 grant from the National Institutes of Health to develop software for commercial applications.

The Small Business Innovation Research grant will be used by the Cleveland-based protein biomarker development and software firm to develop applications for four software programs that it has licensed from Case Western Reserve University, from which NeoProteomics was spun out in 2006.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.